Tech Company Financing Transactions
Pear Therapeutics Funding Round
On 7/8/2020, Pear Therapeutics received $50 million in investment from Perceptive Advisors.
Transaction Overview
Company Name
Announced On
7/8/2020
Transaction Type
Debt
Amount
$50,000,000
Round
Undisclosed
Investors
Perceptive Advisors (Sam Chawla)
Proceeds Purpose
Pear intends to use the proceeds for working capital, repayment of existing debt, and general corporate purposes, including commercialization activities for the Company's three FDA-authorized prescription digital therapeutics (PDTs).
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
200 State St.
Boston, MA 02109
USA
Boston, MA 02109
USA
Phone
Undisclosed
Website
Email Address
Overview
Pear Therapeutics' patented eFormulation approach combines mobile health apps with supplements, medical foods, and pharmaceuticals, to create more efficacious treatment solutions. eFormulations are simple to use. A software access code on the product packaging provides access to Pear's health apps.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/8/2020: MonkeyLearn venture capital transaction
Next: 7/8/2020: OwnBackup venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs